2024 | Pralsetinib in Patients with Advanced/Metastatic Rearranged During Transfection (RET)-Altered Thyroid Cancer: Updated Efficacy and Safety Data from the ARROW Study | Subbiah, Vivek; Hu, Mimi I; Mansfield, Aaron S; Taylor, Matthew H; Schuler, Martin; Zhu, Viola W; Hadoux, Julien; Curigliano, Giuseppe; Wirth, Lori; Gainor, Justin F; Alonso, Guzman; Adkins, Douglas; Godbert, Yann; Ahn, Myung-Ju; Cassier, Philippe A; Cho, Byoung Chul; CHIA-CHI LIN ; Zalutskaya, Alena; Barata, Teresa; Trask, Peter; Scalori, Astrid; Bordogna, Walter; Heinzmann, Sebastian; Brose, Marcia S | Thyroid : official journal of the American Thyroid Association | 1 | | |
2022 | Sunvozertinib, a Selective EGFR Inhibitor for Previously Treated Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations | Wang, Mengzhao; CHIH-HSIN YANG ; Mitchell, Paul L; Fang, Jian; Camidge, D Ross; Nian, Weiqi; Chiu, Chao-Hua; Zhou, Jianying; Zhao, Yanqiu; Su, Wu-Chou; Yang, Tsung-Ying; Zhu, Viola W; Millward, Michael; Fan Y.; Huang, Wen-Tsung; Cheng, Ying; Jiang, Liyan; Brungs, Daniel; Bazhenova, Lyudmila; Lee, Chee Khoon; Gao, Bo; Xu, Yan; Hsu, Wei-Hsun; Zheng, Li; Jänne, Pasi A | Cancer discovery | 39 | 20 | |